Expanding the clinical and immunogenomic relevance of SAMD1 in hepatocellular carcinoma.
0/5 보강
APA
Filho VOC, Passos PRC (2025). Expanding the clinical and immunogenomic relevance of SAMD1 in hepatocellular carcinoma.. Metabolism: clinical and experimental, 171, 156331. https://doi.org/10.1016/j.metabol.2025.156331
MLA
Filho VOC, et al.. "Expanding the clinical and immunogenomic relevance of SAMD1 in hepatocellular carcinoma.." Metabolism: clinical and experimental, vol. 171, 2025, pp. 156331.
PMID
40523558
같은 제1저자의 인용 많은 논문 (4)
- BEND3 is associated with poor prognosis and treatment response in Hepatocellular Carcinoma.
- Neoadjuvant Immune Checkpoint Inhibitors in CSCC: A Systematic Review and Meta-Analysis.
- ADH1C as a robust prognostic biomarker in hepatocellular carcinoma: Evidence from a multi-cohort meta-analysis.
- CCT3 as a promising diagnostic and prognostic biomarker in HCC.